2016
DOI: 10.1186/s13256-016-1144-8
|View full text |Cite
|
Sign up to set email alerts
|

Previously undiagnosed hereditary spherocytosis in a patient with jaundice and pyelonephritis: a case report

Abstract: BackgroundHereditary spherocytosis is autosomal dominant inherited extravascular hemolytic disorder and is the commonest cause of inherited hemolysis in northern Europe and the United States. The classical clinical features of hereditary spherocytosis are anemia, jaundice, and splenomegaly. However, all of these classical features are not always revealed in the case of mild hemolysis or when hemolysis is well compensated. Patients with hereditary spherocytosis may remain undiagnosed for years if their hemolysi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
5
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 3 publications
1
5
0
3
Order By: Relevance
“…We present a 4-year-old male with a history of moderate HS and sickle cell trait without prior splenectomy who presented with infection is a well-known complication, it has only been described in the context of hydroxychloroquine toxicity in subjects with COVID-19. 13 Our patient emphasizes the necessity to follow patients at risk for hemolysis closely in the setting of COVID-19. There are reports of patients with sickle cell disease who were infected with COVID-19, however none have addressed the risk in patients with hemoglobin membrinopathies.…”
Section: Covid-19 and Hereditary Spherocytosis: A Recipe For Hemolysismentioning
confidence: 85%
See 1 more Smart Citation
“…We present a 4-year-old male with a history of moderate HS and sickle cell trait without prior splenectomy who presented with infection is a well-known complication, it has only been described in the context of hydroxychloroquine toxicity in subjects with COVID-19. 13 Our patient emphasizes the necessity to follow patients at risk for hemolysis closely in the setting of COVID-19. There are reports of patients with sickle cell disease who were infected with COVID-19, however none have addressed the risk in patients with hemoglobin membrinopathies.…”
Section: Covid-19 and Hereditary Spherocytosis: A Recipe For Hemolysismentioning
confidence: 85%
“…Patients and care providers are educated on the importance of monitoring for hemolysis during febrile episodes to avoid an array of complications from acute anemia. While hemolysis in patients with HS and viral infection is a well‐known complication, it has only been described in the context of hydroxychloroquine toxicity in subjects with COVID‐19 13 …”
Section: Hospital Day 0 Hospital Day 1 Hospital Day 2 5:52 Am Hospitmentioning
confidence: 99%
“…Ademais, o paciente retorna ao serviço de hematologia anualmente para realizar exames de rotina e avaliar a estabilidade da hemólise. Esse controle anual se mostra eficaz e pode acontecer com menor espaço de tempo caso o paciente apresente infecção por parvovírus 19, dado que este pode desencadear uma aplasia medular, a qual deve ser devidamente controlada 10,7,14 .…”
Section: Discussionunclassified
“…A Esferocitose Hereditária (EH) não se revela como uma condição fatal, mas pode gerar alguns inconvenientes, sendo que as principais complicações da doença estão relacionadas à colelitíase 14,6 . Esta ocorre devido hemólise constante, a qual gera um aumento da concentração de bilirrubina indireta, que precipita dentro da vesícula biliar, culminando na formação de cálculos biliares 11,12 .…”
Section: Introductionunclassified
See 1 more Smart Citation